v3.25.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net revenues $ 3,197,110 $ 2,965,406
Cost of sales 1,801,450 1,848,984
Gross Profit 1,395,660 1,116,422
Operating expenses:    
Research and development 517,275 576,903
Selling, general and administrative 972,409 1,359,415
Total operating expenses 1,489,684 1,936,318
Loss from operations (94,024) (819,896)
Other income (expense):    
Interest income 12,928 25,325
Interest and finance expenses (40,210) (27,901)
Loss from investment (250) (54,750)
Total other income (expense) (27,532) (57,326)
Loss before provision for taxes (121,556) (877,222)
Current 1,500 0
Total benefit (provision) for income taxes 1,500 0
Net loss $ (123,056) $ (877,222)
Basic and diluted loss per common share: (in dollars per share) $ (0) $ (0.01)
Weighted average shares of common stock outstanding - basic and diluted (in shares) 67,588,492 67,588,492